Since the mid-1980s the Gothenburg Paediatric Growth Research Centre (GPGRC), also known at the Växthuset (the growth house), has conducted basic and clinical research in paediatric endocrinology. This research has involved both interdisciplinary and longitudinal research in close collaboration with other institutions and industry in and outside Sweden.
The centre has expertise in conducting and monitoring large scale clinical trials in national and international projects. The centre has a growth laboratory which has developed measures of ultra-sensitivity for hormonal evaluations of very young children. The GPGRC has also participated in consensus work on syndromes such as Turner, Noonan, 22q11 and Silver Russell. The GPGRC holds the National Registry of growth hormone treatment in children. The diabetes group has a broad international research profile and the diabetes unit is designated as a European "center of excellence". The GPGRC is also the national coordinator of the first study on child obesity surgery (the AMOS project).